- Telehealth Visits
- Insurance plan information
Rishi R. Sekar, MD, MSc
He | Him | HisUrologic Oncology- Telehealth Visits
- Insurance plan information
Rishi R. Sekar, MD, MSc
He | Him | HisUrologic Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Rishi R. Sekar is a urological surgeon who cares for patients with cancers of the urinary and reproductive systems, including prostate, bladder, kidney, testicular, adrenal, urethral and penile cancers. He is experienced in both open (traditional) and minimally invasive surgical techniques. To deliver the best possible care, he combines cutting-edge tools with a holistic approach that takes each patient's unique experiences into consideration.
Sekar's research focuses on improving cancer care delivery, with an emphasis on addressing disparities through a better understanding of the social determinants of health (economic and environmental factors that affect well-being). He also studies the evolving role that safety net hospitals – which largely serve patients who have either Medicaid or no insurance – play in providing cancer care to vulnerable populations.
Sekar earned his medical degree at Emory University. He completed a residency in general surgery at the University of Washington, followed by a fellowship in urological oncology at the University of Michigan. He also completed a postdoctoral fellowship in health services and policy research through the National Clinician Scholars Program.
Education & training
Fellowship
- Urologic Oncology, University of Michigan Hospitals GME
Residency
- Urology, University of Washington Medical Center
Internship
- General Surgery, University of Washington Medical Center
Degree
- MD, Emory University School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225489%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225489%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-5 of 5 reviews
- January 20, 20265 out of 5 Stars
Dr Sekar is wonderful. So engaging and made me at ease.
- December 3, 20255 out of 5 Stars
Dr Rishi Sekar-Urologist, Surgeon, Oncologist, has been gracious, patient and reassuring. In spite of the numerous questions (my research on recurring RCC prompted) As an ICU RN-Nurse Practitioner, with fairly high anxiety, I am acutely conscious that highly anxious patients can be stressful on providers. Dr Sekar has been uniquely very informative, supportive, and cautiously optimistic without ever making me feel uncomfortable about my anxiety. After our second meeting, the acute sense of dread I was feeling in the six weeks after my diagnosis shifted dramatically to one of hopeful optimism. Which has/is making the intervening month awaiting surgery bearable. For that I am very grateful to Dr Sekar.
- November 10, 20255 out of 5 Stars
I would rate Dr. Sekar as excellent if that option was available. He made me feel completely comfortable with his knowledge and what I'll call "bedside manner", something not often found in the medical profession.
- October 25, 20255 out of 5 Stars
Dr. Sekar is fantastic!! He takes his time, explains things so well, and is "present" in our appointments. He answers all of my questions (and there's always a lot of them) and never makes me feel like he's rushing to get to the next patient.
- October 20, 20255 out of 5 Stars
Dr Sekar was reassuring, compassionate, kind. I came into my initial consultation a bit edgy, worried, about my indicators of cancer in my prostate. I left this appointment feeling like I was back in control and had someone on my side who had my back.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.